Literature DB >> 28274993

Hypocalcemia in a Patient with Cancer.

Mitchell H Rosner1.   

Abstract

Entities:  

Keywords:  Humans; Neoplasms; Thyroidectomy; denosumab; hypocalcemia; parathyroid hormone

Mesh:

Substances:

Year:  2017        PMID: 28274993      PMCID: PMC5383396          DOI: 10.2215/CJN.13241216

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  23 in total

1.  A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.

Authors:  Larissa K Laskowski; David S Goldfarb; Mary Ann Howland; Kelly Kavcsak; Danny M Lugassy; Silas W Smith
Journal:  J Med Toxicol       Date:  2016-03-17

2.  Albumin-corrected calcium and ionized calcium in stable haemodialysis patients.

Authors:  C M Clase; G L Norman; M L Beecroft; D N Churchill
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

3.  Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.

Authors:  S M Suh; A H Tashjian; N Matsuo; D K Parkinson; D Fraser
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

Review 4.  Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.

Authors:  Myrick C Shinall; Kathryn McCrystal Dahir; James T Broome
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

5.  Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support.

Authors:  Roland N Dickerson; Kathryn H Alexander; Gayle Minard; Martin A Croce; Rex O Brown
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 May-Jun       Impact factor: 4.016

6.  Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency.

Authors:  R K Rude; J S Adams; E Ryzen; D B Endres; H Niimi; R L Horst; J G Haddad; F R Singer
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

7.  Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status.

Authors:  J H Ladenson; J W Lewis; J C Boyd
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

8.  Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting.

Authors:  Andrew Liem Hieu Huynh; Scott Thomas Baker; Andrew James Stewardson; Douglas Forsyth Johnson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-06-03       Impact factor: 2.890

9.  Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism.

Authors:  Tasuku Saito; Seiji Fukumoto
Journal:  Int J Pediatr Endocrinol       Date:  2009-10-07

10.  Suppression of Parathyroid Hormone in a Patient with Severe Magnesium Depletion.

Authors:  Sangeeta Mutnuri; Isaac Fernandez; Tina Kochar
Journal:  Case Rep Nephrol       Date:  2016-04-14
View more
  2 in total

1.  Elevated parathyroid hormone levels in older women treated for osteoporosis using denosumab.

Authors:  Abayomi N Ogunwale; Fariha Hameed; Luis Valdez; Jude des Bordes; Maryam Jamil; Nahid Rianon
Journal:  Eur Geriatr Med       Date:  2021-09-29       Impact factor: 1.710

2.  Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.

Authors:  Jarred Strickling; Michael J Wilkowski
Journal:  Case Rep Nephrol Dial       Date:  2019-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.